Sandu Pharmaceuticals standalone net profit rises 73.91% in the September 2020 quarter
Sales rise 45.56% to Rs 17.22 crore
Net profit of Sandu Pharmaceuticals rose 73.91% to Rs 0.40 crore in the quarter ended September 2020 as against Rs 0.23 crore during the previous quarter ended September 2019. Sales rose 45.56% to Rs 17.22 crore in the quarter ended September 2020 as against Rs 11.83 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales17.2211.83 46 OPM %3.433.97 -PBDT0.690.49 41 PBT0.550.35 57 NP0.400.23 74Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 16 2020 | 8:51 AM IST